Senvera Therapeutics, Inc. A Curie.Bio Company
Restoring Smell and Taste with Neuroregenerative Genetic Medicines
health AI/biotech regenerative medicine
StageCurie.Bio-backed
Founded2022
Employees9
LocationBoston, MA
About
Senvera Therapeutics' mission is to translate compelling foundational science into transformative regenerative therapies for patients living with age-related olfactory loss, or presbyosmia, a highly prevalent disease of ageing associated with increased morbidity and 10-year mortality, and for which there are no approved therapies. Our strategy seeks to exploit a deep understanding of pathology and molecular mechanisms that regulate the peripheral olfactory stem cell niche. Rhino Therapeutics, Inc is funded by Curie.Bio. For more information please visit https://curie.bio/
Product
- Value proposition
- We develop regenerative therapies that translate cutting-edge science into meaningful solutions for patients with no current treatment options for olfactory loss.
- Target customers
- partnerships and investors in biotechnology and pharmaceutical development
Founders
- Graham Wynne — Founder, CTO
- Andy Mulvaney — Founding CEO
- Kleanthis G. Xanthopoulos — President & Chief Executive Officer
Categories
biotechregenerative medicineneuroscienceolfactory/taste restoration
Products
neuroregenerative genetic medicinesTherapies for olfactory restoration
Key features
regenerative therapiesneuroregenerative genetic medicinestranslation of cutting-edge science into treatments
Technologies
genetic medicinesneuroregenerationregenerative biotechnology
Target conditions
olfactory lossanosmiagustatory dysfunctionsmell and taste disorders
Care settings
labresearchclinical development
Partnerships
Explore partnership and investment opportunities with Senvera to help advance the future of regenerative biotechnology.
Investors
Curie.Bio
News
- Chad Viergever - Corp Dev at Senvera Therapeutics | USC MBA · 2025-12-15T00:00:00.000Z
- Curie.Bio · 2025-09-20T00:00:00.000Z
- Biopharma Insights - November 2025 - LinkedIn · 2025-11-07T00:00:00.000Z
- Analyzing Biotech Financings Beyond Headline Numbers - LinkedIn · 2026-04-27T00:00:00.000Z
- Addressing Antimicrobial Resistance with Innovative Science · 2026-04-21T00:00:00.000Z
- Interview with Rory Mullen - Head of Biopharma and Food, IDA Ireland · 2026-05-29T00:00:00.000Z
More links
Browse similar startups
Related startups
- Shaws Pharmacy — Shrewsbury, MA
- Sidekick Bio — Boston, MA
- siRNAgen Therapeutics — Cambridge, MA
- Stipple Bio — Cambridge, MA
- The Part-Time Benefits Company — Billerica, MA
- Torus Biosystems — Medford, MA
- Symbiome — San Francisco, CA
- Synamics Therapeutics — Beverly Hills, CA
- TwoStep Therapeutics — San Carlos, CA
- Acrobat Genomics — San Carlos, CA
- AivoCode — San Diego, CA
- Arialys Therapeutics — La Jolla, CA
Profile updated Jul 29, 2026. Sources: rhinotherapeutics.com, senveratx.com, linkedin.com
